Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20253547
- Approval Date
- Mar 4, 2025
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20243217
- Approval Date
- Feb 23, 2024
NMPA
Compound Aspartate，Vitamin B6 and Dipotassium Glycyrrhetate Eye Drops
- Product Name
- 复方门冬维甘滴眼液
- Approval Number
- 国药准字H20083254
- Approval Date
- Jan 9, 2023
NMPA
Diclofenac Sodium Eye Drops
- Product Name
- 双氯芬酸钠滴眼液
- Approval Number
- 国药准字H20067176
- Approval Date
- Nov 26, 2021
NMPA
Ketotifen Fumarate Eye Drops
- Product Name
- 富马酸酮替芬滴眼液
- Approval Number
- 国药准字H20073216
- Approval Date
- Jul 30, 2021
NMPA
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
- Product Name
- 萘敏维滴眼液
- Approval Number
- 国药准字H20064223
- Approval Date
- Feb 23, 2021
NMPA
Sodium Chloride Eye Drops
- Product Name
- 氯化钠滴眼液
- Approval Number
- 国药准字H20103764
- Approval Date
- Aug 19, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found